ABCC1 and lung carcinoma: For example, a positively charged cationic liposome containing siRNA in combination with doxorubicin effectively inhibits the activity of B cell lymphoma-1 (BCL-1) and multidrug-resistance-associated protein-1 (MRP1) in H69AR lung cancer lines [123].